The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's opposition to ...

GlaxoSmithKline (GSK) is to collaborate with the Francis Crick Institute, a new powerhouse of academic- and charity-funded biomedical research based in London. The new partnership is expected to ...

Pfizer reportedly offered about 618 million shares through a placement with investors, according to a Wednesday statement.

Pharmaceutical company GSK will no longer set diversity targets as it became the latest firm to abandon inclusivity goals. The British medicine producer has followed several companies which have ...

Any purchases of Ordinary Shares by GSK from Citi under the First Tranche will be carried out on the London Stock Exchange. Published first on TheFly – the ultimate source for real-time ...

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US ...

Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it joined the stock market in 2022.

Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...